Your browser doesn't support javascript.
Clinical study of use of remdesivir and tocilizumab in severely ill covid-19 patients
Journal of Association of Physicians of India ; 69(7):14-18, 2021.
Article in English | Scopus | ID: covidwho-1359618
ABSTRACT

Introduction:

Remdesivir and Tocilizumab are two experimental drugs used in severely ill COVID-19 patients. Various clinical trials studying these drugs are giving conflicting results. Our aim is to study these two drugs and share the experience in our setting.

Methods:

Our Study is a retrospective analysis of Clinico-laboratory details and outcome of three groups of patients who were given either (i) Remdesivir or (ii) Tocilizumab or (iii)both Remdesivir and Tocilizumab . We compared the outcome of these patients with other patients who did not receive either of these drugs, when it was not available or not introduced as experimental drugs earlier in treatment guidelines.

Results:

Out of a total of 521 patients, in the above three groups who received either or both Remdesivir or Tocilizumab, 334 survived. Out of 214 patients who did not receive any of the two drugs only 74 survived. The outcome was better individually for all the three groups of patients receiving either or both of the drugs as compared to neither of the drugs.(p <0.01)

Conclusion:

Remdesivir and Tocilizumab were useful drugs in treatment of severely ill covid -19 patients as compared with the patients who did not receive any of the above drugs. © 2021 Journal of Association of Physicians of India. All rights reserved.
Search on Google
Collection: Databases of international organizations Database: Scopus Type of study: Prognostic study Language: English Journal: Journal of Association of Physicians of India Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS

Search on Google
Collection: Databases of international organizations Database: Scopus Type of study: Prognostic study Language: English Journal: Journal of Association of Physicians of India Year: 2021 Document Type: Article